Invest in intelligence that delivers

Contact
Search
Close this search box.

Ocrevus Predicted to Be a Billion-dollar Blockbuster

From: Multiple Sclerosis News Today
By: Ed Tobias

Multiple Sclerosis News Today

The research firm Spherix Global Insights, which analyzes trends in the pharmaceutical industry, predicts that Ocrevus is “poised to blow past the $1B mark in the coming year. …” (read more).

Sign up for alerts, market insights and exclusive content in your inbox.
Subscribe
Linkedin

Download our publication plan

or

Visit our portal for the searchable format

©2024 Spherix. All Rights Reserved.

Site Map

Sign up for alerts, market insights and exclusive content in your inbox.

Spherix is excited to announce our expansion into an additional, rapidly evolving specialty market:

HEMATOLOGY

Throughout 2024, we will be publishing over
10 groundbreaking studies covering a wide range of indications within classical hematology.